Highlight selection of radiochemistry and radiopharmacy developments by editorial board - Université d'Angers Accéder directement au contenu
Article Dans Une Revue European Association of Nuclear Medicine, issuing body - EJNMMI radiopharmacy and chemistry Année : 2021

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Oliver C Neels
  • Fonction : Auteur
  • PersonId : 1109629
Wiktor Szymanski

Résumé

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. Conclusions: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Domaines

Cancer
Fichier principal
Vignette du fichier
FaivreChauvet2021Eq13.pdf (1.37 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

inserm-03338402 , version 1 (08-09-2021)

Identifiants

Citer

Francisco Alves, Inês F Antunes, Emiliano Cazzola, Frederik Cleeren, Bart Cornelissen, et al.. Highlight selection of radiochemistry and radiopharmacy developments by editorial board. European Association of Nuclear Medicine, issuing body - EJNMMI radiopharmacy and chemistry, 2021, 6, pp.31. ⟨10.1186/s41181-021-00146-9⟩. ⟨inserm-03338402⟩
124 Consultations
84 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More